Literature DB >> 15267170

Medullary thyroid carcinoma.

Erik G Cohen1, Ashok R Shaha, Alessandra Rinaldo, Kenneth O Devaney, Alfio Ferlito.   

Abstract

Entities:  

Mesh：

Year:  2004        PMID： 15267170     DOI： 10.1080/00016480310015704

Source DB:  PubMed          Journal:  Acta Otolaryngol        ISSN： 0001-6489            Impact factor:   1.494


× No keyword cloud information.
  4 in total

1.  Evolving paradigms for successful molecular imaging of medullary thyroid carcinoma.

Authors:  Domenico Rubello; Ka Kit Wong; Maria Cristina Marzola; Mohsen Beheshti; Valentina Ambrosini; Sotirios Chondrogiannis; Milton D Gross
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-04       Impact factor: 9.236

2.  The value of 18F-DOPA PET-CT in patients with medullary thyroid carcinoma: comparison with 18F-FDG PET-CT.

Authors:  Mohsen Beheshti; Sigrid Pöcher; Reza Vali; Peter Waldenberger; Gabriele Broinger; Michael Nader; Susanne Kohlfürst; Christian Pirich; Henning Dralle; Werner Langsteger
Journal:  Eur Radiol       Date:  2009-01-21       Impact factor: 5.315

3.  Serum calcitonin negative medullary thyroid carcinoma.

Authors:  Michael Sand; Marcos Gelos; Daniel Sand; Falk G Bechara; Gerd Bonhag; Ellen Welsing; Benno Mann
Journal:  World J Surg Oncol       Date:  2006-12-21       Impact factor: 2.754

4.  Simultaneous ectopic adrenocorticotropic hormone syndrome and adrenal metastasis of a medullary thyroid carcinoma causing paraneoplastic Cushing's syndrome.

Authors:  Michael Sand; Samuel Uecker; Falk G Bechara; Marcos Gelos; Daniel Sand; Till H Wiese; Benno Mann
Journal:  Int Semin Surg Oncol       Date:  2007-07-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.